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Vitamin B12 is made by only certain prokaryotes yet is required by a number of eukaryotes 
such as mammals, fish, birds, worms and Protista, including algae. There is still much to learn 
about how this nutrient is trafficked across the domains of life. Herein, we describe ways to 
make a number of different corrin analogues with fluorescent groups attached to the main 
tetrapyrrole-derived ring. A further range of analogues were also constructed by attaching 
similar fluorescent groups to the ribose ring of cobalamin, thereby generating a range of 
complete and incomplete corrinoids to follow uptake in bacteria, worms and plants. By using 
these fluorescent derivatives we were able to demonstrate that Mycobacterium tuberculosis 
is able to acquire both cobyric acid and cobalamin analogues, that Caenorhabditis elegans 
takes up only the complete corrinoid, and that seedlings of higher plants such as Lepidium 




The cobamides encompass a group of closely structurally related nutrients, cofactors and 
coenzymes that harbour a cobalt-containing corrin ring, and are often loosely referred to as 
vitamin B12 (Figure 1)(Renz, 1999; Warren, et al., 2002). These molecules vary in the nature 
of the upper ligand attached to the cobalt and the character of the lower nucleotide loop. 
Cobalamin, for instance, contains dimethylbenzimidazole as the base in the nucleotide loop 
but this is replaced with adenine in pseudocobalamin (Figure 1) (Degnan, et al., 2014; Maggio-
Hall and Escalante-Semerena, 2003). In the biologically active forms of cobalamin the cobalt 
ion is normally either adenosylated (adenosylcobalamin) or methylated (methylcobalamin) 
(Banerjee and Ragsdale, 2003) whilst vitamin B12 represents the cyanolated derivative of 
cobalamin that is produced during the commercial extraction and isolation of the nutrient 
(Martens, et al., 2002). However, the term B12 is frequently used to refer to all forms of 
cobalamin. 
Cobamides are produced exclusively by certain prokaryotes (Roth, et al., 1996). Apart from 
cobalamin and pseudocobalamin, further variants with shorter nucleotide chain lengths and/or 
alternative nucleotide bases are synthesized by different bacteria (Degnan, et al., 2014; 
Krautler, et al., 2003; Renz, 1999). Cobamides are made via either an anaerobic or aerobic 
biochemical pathway, both involving around thirty enzyme-mediated steps (Blanche, et al., 
1995; Deery, et al., 2012; Moore, et al., 2013; Warren, et al., 2002). The key steps of the 
aerobic pathway are shown in Figure 1, which concisely depicts contraction of the tetrapyrrole 
ring, insertion of the cobalt ion and building of the nucleotide loop. Variations in the 
construction of the lower nucleotide loop, mediated by different substrate preferences for 
bases and linkers (Figure 1) during its biosynthesis, give rise to the assorted cobamides that 
are found in nature (Chan and Escalante-Semerena, 2011; Crofts, et al., 2013; Krautler, et al., 
2003; Maggio-Hall and Escalante-Semerena, 2003; Zayas, et al., 2007). Many prokaryotic 
microorganisms (Allen and Stabler, 2008; Degnan, et al., 2014; Gray and Escalante-
Semerena, 2009) and microbial eukaryotes (Croft, et al., 2005; Helliwell, et al., 2016) rely on 
other producers of cobamides, where both bacteria and archaea can be counted, and 
therefore have to recover the nutrient from the environment they inhabit. Such salvage 
systems often involve remodelling of the lower nucleotide loop to produce the corrin variant 
that suits the new host. 
In this respect bacteria, as well as archaea, can be divided into a range of classes with regards 
to their B12 requirements. There are bacteria that make their own cobalamin, those that are 
auxotrophic for the nutrient, those that require cobalamin for some non-essential processes 
and those that do not require the nutrient at all. In this way the nutrient plays an important role 
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in bacterial ecology, especially in complex microbial communities (Degnan, et al., 2014; 
Helliwell, et al., 2016). However, little is known about the movement of cobamides in such 
communities, whether it is specifically shared or exchanged in mutualistic or symbiotic 
relationships. 
Bacteria are also the source of cobalamin for a large number of eukaryotes that require the 
nutrient for either specific methylation or isomerisation reactions. For instance, approximately 
50% of all microalgal species require cobalamin for growth, and it has been shown that 
bacteria can provide this compound in course of a symbiotic exchange for photosynthate 
(Croft, et al., 2005). Similarly, enteric bacteria are the source of cobalamin (Roth, et al., 1996) 
in ruminants such as cattle and, as dairy products and meat represent a major form of human 
dietary cobalamin, are therefore also responsible for most of the cobalamin found in humans 
(Brito, et al., 2015; Girard, et al., 2009). Other eukaryotes, including nematode worms (Yilmaz 
and Walhout, 2014), fish (Greibe, et al., 2012) and birds (Zaman and Zak, 1989) have to 
acquire cobalamin as part of their diets from B12-producing bacteria. Within eukaryotic cells 
cobalamin is further compartmentalised, with methylcobalamin found in the cytoplasm 
associated with methionine synthase and adenosylcobalamin located within the mitochondria 
with its cognate enzyme methylmalonyl CoA mutase (Gherasim, et al., 2013; Watkins and 
Rosenblatt, 2013). There is the added complication of translocation through the body of 
multicellular organisms, requiring some form of vascular transport. 
Therefore, from their prokaryotic origins, cobamides such as cobalamin undergo a complex 
journey through many different domains and kingdoms of life, a journey that involves 
scavenging, recycling, modification and compartmentalisation. In terms of understanding the 
role played by cobamides in ecology, health and disease there is a need to devise sensitive 
methods to follow the nutrient on this biological voyage. Following the movement of cobamides 
has proved difficult as the nutrient is normally required in small quantities. One way of following 
cobamides along their transformation and transportation chain is to use fluorescent derivatives 
coupled to the cobalamin molecule to allow its detection via fluorescence microscopy (Lee 
and Grissom, 2009; Smeltzer, et al., 2001). The most common of these fluorescent cobalamin 
derivatives involve attachment of a fluorophore to either the cobalt ion or to the ribose ring of 
the lower nucleotide. However, attachment to the cobalt ion involves modifications that are 
usually light sensitive whereas conjugation to the ribose can be easily removed through 
nucleotide loop remodelling when such molecules are taken up by bacteria. Attachment of 
fluorophores to the side chains of the corrin macrocycle have also been reported. However, 
this attachment requires the hydrolysis of one of the amide side chain and the separation of a 
range of derivatives prior to the modification. This is low yielding process. Alternatively, a 
fluorophore could also be attached to the carboxylic acid side chain of cobyric acid, but this 
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would prevent the molecule from being converted into a cobalamin analogue in vivo. Herein, 
we describe ways to attach fluorophores directly to the C5 position of the corrin ring according 
to our understanding of how the corrin ring is constructed. We also report on which of these 
C5-modified corrin variants, together with some ribose-modified fluorophores, are taken up by 






Synthesis of C5-allyl HBA. The transformation of uroporphyrinogen III into a corrin involves, 
amongst other events, the addition of 8 S-adenosyl-L-methionine (SAM) derived methyl 
groups, the last of which is added to the C5 position (Deery, et al., 2012; Warren, et al., 2002). 
We hypothesized that it may be possible to use SAM analogues, with extended chain lengths, 
to alkylate the C5 position (Figure 2). This requires the isolation of precorrin-7, the substrate 
for the final methyltransferase, CobL. We recently reported the construction of a recombinant 
E. coli strain from which precorrin-7 can be purified (Deery, et al., 2012). Methylation of 
precorrin-7 by CobL generates precorrin-8, which is isomerised by CobH to generate 
hydrogenobyrinic acid (HBA). We sought to modify the C5 position by employing an allyl 
analogue of SAM (Dalhoff, et al., 2006; Dalhoff, et al., 2006) with a view to making the 
respective C5-modified HBA derivative (C5-allyl HBA) (Figure 2).  
 
When precorrin-7 was incubated with CobL, CobH and allyl-SAM the colour of the solution 
changed from yellow to orange consistent with the expected enzymatic transformation. The 
observed shift in the UV-visible spectrum of the starting material with a maximum absorption 
at 400 nm to a new species with maxima at 328, 520 and 555 nm is characteristic of the 
formation of a HBA-like molecule. Analysis of the reaction mixture by HPLC-MS identified a 
new compound with m/z 907.4 (Figure S1). The observed increase in mass and change in 
UV-visible spectrum confirms the addition of an allyl group to the macrocycle and indicates 
that migration of the C11 methyl group to C12 has occurred. 
 
The yield of allyl-HBA obtained from this initial reaction was less than 50%, with the other 
major product being allyl-precorrin-8. The presence of allyl-precorrin-8 suggested that CobH 
is the rate limiting step in this reaction sequence. We considered that the lower activity of 
CobH could be due to spatial constraints resulting from the larger substrate and therefore we 
decided to make a number of structure-based (Shipman, et al., 2001) mutations that would 
introduce more space into the active site, especially around the region of the protein where 
the C5 position of the substrate is found. One of these mutations, T85A, did indeed 
significantly improve the yield, such that the C5-allyl-HBA was obtained in greater than 85% 
yield. 
 
The structure of the product was further confirmed as being C5-allyl-HBA by X-ray 
crystallography. This was achieved by determining the structure of the CobHT85A-C5-allyl-HBA 
product complex at 1.6 Å resolution (Figure 3, Table S1). The extended alkyl group at the C5 
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position is clearly seen in the structure. Although the T85A mutation of CobH does increase 
the size of the active site around the C5 position, the allyl group is still constrained, suggesting 
that further enhancement could be afforded with more rational engineering. The PDB 
coordinates are deposited under the code 5N0G. 
 
We also explored the synthesis of C5-propargyl-HBA using a propargyl SAM derivative 
(Dalhoff, et al., 2006). To achieve this outcome it was necessary to prepare the respective 
SAM analogue in situ from Se-propargyl-L-homocysteine using a modified SAM synthetase 
(I117A mutant of hMAT 2A) as the propargyl-SAM analogue is not stable at physiological pH 
(Wang, et al., 2013; Wang, et al., 2014). Incubation of precorrin-7 with Se-propargyl-Hcy, Mg-
ATP, hMAT 2A I117A, CobL, CobHT85A, resulted in the same characteristic shift in the UV-
visible spectrum associated with the formation of a HBA like chromophore. Analysis of the 
purified product by HPLC-MS confirmed the addition of a propargyl group with an observed 
m/z of 905.4 (Figure S1). This approach demonstrated that a number of C5-derivatives could 
be made using activated SAM variants. The propargyl-compounds have the advantage of 
being able to be used with click chemistry approaches for further functionalisation. 
 
Conversion of the C5-allyl-HBA to its cobyric acid form. The conversion of HBA to HBA 
a,c-diamide (HBAD) is mediated by CobB, which amidates the acetic acid side chains attached 
to the C2 and C7 positions of the corrin framework (Figure 2) (Crouzet, et al., 1990). Incubation 
of CobB with C5-allyl-HBA, in the presence of glutamine and Mg-ATP, resulted in the 
production of C5-allyl-HBAD. The product of the reaction was found to have a shorter retention 
time on the HPLC column and a 2-mass unit decrease in comparison to the starting material, 
all of which is consistent with the amidation of the a and c sidechains. 
 
In the aerobic biosynthesis of cobalamin, HBAD undergoes cobalt chelation and adenosylation 
prior to the completion of the amidation reactions by CobQ (Blanche, et al., 1995). However, 
the light sensitive nature of the adenosylated intermediate make this a difficult compound with 
which to do further modifications. We thus sought a way to by-pass the metal-insertion stage 
of the pathway in order to complete the amidation of HBAD to generate hydrogenobyric acid 
(Hby), the cobalt-free analogue of cobyric acid. This was achieved by using the CobQ from 
Allochromatium vinosum, an organism that was shown to accumulate cobalt-free corrinoids 
when grown in the absence of cobalt (Koppenhagen, et al., 1973). The purified recombinant 
A. vinosum CobQ, in the presence of glutamine and Mg-ATP, did indeed catalyse the 
amidation of the b, d, e and g side chains of HBAD, to generate Hby. Similarly, the enzyme 
also accepted the C5-allyl-HBAD as a substrate and converted it into C5-allyl Hby (Figure 2), 
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whose structure was confirmed by HPLC-MS (m/z 901) (Figure S1) and 2D heteronuclear 
NMR spectroscopy (Figure S2 and Table S2). 
 
Transformation of the C5-allyl HBA analogues into cobyric acid analogues. The allyl-
group was modified to a primary amine through a thiol-ene reaction by reacting the C5-allyl-
Hby with cysteamine in the presence of the radical initiator VA-044 (2,2'-Azobis[2-(2-
imidazolin-2-yl)propane]dihydrochloride) (Figure 2). The reaction product, C5-(2-thiopropane-
1-aminoethane (TPEA))-Hby, was confirmed by HPLC-MS (Figure S1). Cobalt was inserted 
chemically using CoCl2 in dilute aqueous ammonia at elevated temperature. The reaction was 
quenched with KCN and the product was purified by RP18 chromatography. The structure of 
the C5-(TPEA)-cobyric acid was confirmed by HPLC-MS (Figure S1) and NMR (Figure S3 and 
Table S2). Together, all of these steps demonstrate how a combination of in vitro enzyme-
mediated transformations coupled with chemical approaches allow the construction of a 
regiospecifically derivatised form of cobyric acid (Figure 2). 
 
C5 Fluorophore attachment. To attach the fluorophores BODIPY® TR-X (BoD) and Oregon 
Green® 514 (OG) to the terminal amine of the C5 extension, the amine was reacted with the 
N-hydroxysuccinimide ester of the fluorophore (Figure 2). All of the products were analysed 
by HPLC-MS and purified by semi-preparative HPLC. As a result it was possible to generate 
both BoD and OG C5-linked forms of cobyric acid (Figure 4). These compounds were further 
characterised in terms of their functionality and uptake in biological systems as described 
below. 
 
Synthesis of ribose linked analogues. The ribose linked analogues were synthesised by 
carbonyldiimidazole coupling of ethylene diamine to the C5-OH of the ribose moiety of vitamin 
B12, then the primary amine was linked to the N-hydroxysuccinimide ester of either OG or BoD 
(Figure 4). These were made following previously published methods for the construction of 
ribose-linked analogues of cobalamin (Horton, et al., 2003; McEwan, et al., 1999). The 
products were analysed by HPLC-MS, and purified by semi-preparative HPLC. Making both 
fluorescently labelled cobyric acid and cobalamin derivatives provided the opportunity to 
compare their respective activities in terms of their ability to be transported into biological 
systems and ability to act as functionalised nutrients. 
 
Biological activity of the corrin analogues. The biological activity of the C5-cobyric acid 
analogues as well as the ribose-linked derivatives was investigated initially by comparing their 
effect in a B12-dependent microbial bioassay (Raux, et al., 1996). In this case, an agar plate 
embedded with B12-dependent reporter strain of Salmonella enterica (AR3612; cysG, metE) 
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was used to detect growth around an application point, where the size of any resulting growth 
circle can be measured against growth observed with known amounts of B12. With the 
microbial bioassay we looked at the efficacy of the C5-(TPEA) cobyric acid, the BoD and OG 
C5-cobyric acid as well as the BoD and OG ribose analogues of cobalamin to support growth 
of the strain. The observed growth circles can be seen in Figure 5. We were initially surprised 
to see that the C5-(TPEA)-cobyric acid and the two fluorescently labelled versions of cobyric 
acid and cobalamin all promoted growth, albeit they needed to be added at much higher 
concentrations than cyanocobalamin. The requirement for a higher concentration of the 
analogue not only likely reflects poorer molecular recognition by the uptake mechanism but 
also recognition by methionine synthase. The cobalamin-derivatives were more active than 
the C5-analogues, and the OG derivatives were more active than the corresponding BoD 
compounds. The reduced efficacy of the cobyric acid analogues in comparison to the 
cobalamin analogues is probably because the cobyric acid intermediates have to be converted 
into cobalamin forms before growth can occur.  
 
Uptake of analogues into bacteria. We next investigated the uptake of the fluorescent forms 
of cobyric acid and cobalamin into E. coli BL21 (DE3). The BL21 strain has a mutation in btuB, 
which encodes the outer membrane transport component of the cobalamin uptake system 
(Studier, et al., 2009). To overcome this limitation, the BL21 cells were transformed with 
pLysS-btuB and induced overnight with IPTG at which point 1 µM of the OG analogues were 
added. The bacteria were then imaged by widefield fluorescence microscopy and the resulting 
images demonstrated that whilst E. coli is able to take up both OG fluorescent analogues, 
significantly greater fluorescence was observed with the cobalamin derivative suggesting that 
it is taken up more efficiently. 
 
For the BoD analogues, E. coli OP50 cells were transformed with a plasmid harbouring both 
btuB and btuF (pET-BAD-btuB-btuF), where btuF encodes the periplasmic cobalamin binding 
protein of the B12 transporter. These were cloned in order to ensure maximal uptake of the 
corrin analogues, which were added to a final concentration of 1 µM at the same time as the 
cells were induced. Cells were incubated separately with either C5-BoD-cobyric acid, ribose-
BoD-cobalamin or the unattached BoD fluorophore. As judged by the internal fluorescence of 
the bacteria, both the C5-BoD and ribose-BoD analogues were seen to accumulate within the 
cells, indicating that these compounds can be used to monitor transport into E. coli (Figure 5). 
No internal fluorescence was observed with the unattached BoD fluorophore. The significance 
of using E. coli OP50 is that this strain can also be used as a source of food for nematodes 




The BoD analogues of cobalamin were also incubated with E. coli BL21 (DE3) and JM109 
cells. No fluorescence was observed with the BL21(DE3) cells indicating that the defective 
btuB gene prevent uptake of the analogue even at high (1 µM) concentrations. In contrast, 
uptake of the C5-BoD-cobyric acid analogue into JM109 cells was detectable at levels of 10 
nM, whilst the ribose-BoD-cobalamin analogues was detectable at a concentration of 100 nM 
(Figure S4). These results demonstrate that the uptake of the analogues is dependent upon 
the presence of a functional BtuB and that there is some variance between the analogues in 
regard to molecular recognition by the uptake mechanism.  
 
There is always the possibility that the fluorescently labelled compounds undergo breakdown 
within the cell. To investigate the possibility of the breakdown of the analogues, we extracted 
both the ribose-OG-cobalamin and the C5-BoD-cobyric acid analogue from E. coli that had 
been grown in their presence. In both cases we were able to extract the analogues intact from 
the cells after several days growth. No evidence for degradation of the compounds was 
observed (Figure S5) 
 
We also investigated the uptake of the BoD analogues into Mycobacterium tuberculosis. 
Although M. tuberculosis has a B12 pathway it is missing CobF (Gopinath, et al., 2013; 
Rodionov, et al., 2003) and cannot make its own cobalamin. Moreover, M. tuberculosis has a 
different B12 uptake mechanism, employing BacA as a transporter (Gopinath, et al., 2013). We 
investigated B12 uptake into a B12-dependent strain of M. tuberculosis, H37Rv, which carries a 
mutation in metE (H37Rv-metE) (Warner, et al., 2007). After growth LQ 6DXWRQ¶V GHILQHG
medium, supplemented with either the C5-BoD-cobyric acid or the ribose-BoD-cobalamin, the 
cells were found to be fluorescent after 24 and 48 hours respectively using fluorescence 
microscopy (Figure 5). It is clear, therefore, that M. tuberculosis can take up analogues of both 
cobyric acid and cobalamin and that both of these can support growth. 
 
B12 uptake into C. elegans. Several recent papers have demonstrated that a free-living 
nematode C. elegans represents a good eukaryotic model system to study B12 as a nutrient 
(Bito, et al., 2013; Bito, et al., 2017; Watson, et al., 2014). Like humans, C. elegans requires 
B12 for the activities of both B12-dependent methionine synthase and methylmalonyl CoA 
mutase. Thereby, B12 deficiency causes infertility, retarded growth and reduced lifespan (Bito, 
et al., 2013). Bioinformatic analysis has revealed the presence in the C. elegans genome of 
genetic orthologues associated with human inherited B12 disorders but, interestingly, there is 
no evidence of the main B12 binding and trafficking proteins such as intrinsic factor or 
transcobalamin (Yilmaz and Walhout, 2014). To investigate B12 uptake into C. elegans, 
nematodes of the N2 Bristol strain were fed with E. coli OP50 that had been grown in the 
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presence of either C5-BoD-cobyric acid, ribose-BoD-cobalamin, or unattached BoD. L4 worms 
that had been grown in the presence of these analogues since their embryonic stage were 
imaged on a confocal microscope. Only worms fed on E. coli containing the ribose-BoD-
cobalamin revealed any fluorescence within the body. Interestingly, confocal microscopy 
revealed that in these worms the fluorescence was localised to discrete spots in the head, 
vulva and tail regions, corresponding to the coelomocytes (Figure 6). Even within this discrete 
cell type, the fluorescence appears to show a degree of sub-cellular localisation or 
compartmentalisation (Figure 6). This result demonstrates that C. elegans is able to absorb 
and retain the BoD-labelled cobalamin (which was concentrated in some organs), whereas 
retention of the C5-cobyric acid analogue was clearly absent. 
 
B12 uptake into higher plants.  
It is generally accepted that land plants neither make nor require B12 and live in a B12-less 
world. Early reports suggesting that some plants contained B12-dependent enzyme activity 
were later put down to bacterial contamination. However, there does appear to be some 
evidence suggesting that some plants can at least take up and transport cobalamin if the 
nutrient is cultivated with organic fertilisers or if plants are grown in B12-enriched media 
(Mozafar, 1994; Sato, et al., 2004). 
To investigate this observation further, we instigated an outreach project with a local 
secondary school, where pupils grew Lepidium sativum (garden cress) aseptically on an agar 
medium containing increasing concentrations of vitamin B12. After growth for 7 days the 
cotyledons from the germinating seedlings were removed, washed and homogenised. The 
soluble supernatant after centrifugation was then applied to bioassay plates, which 
demonstrated that the seedlings were able to absorb cobalamin from the growth medium in a 
concentration dependent manner (Figure S6). To confirm the ability of L. sativum to absorb 
cobalamin we repeated the uptake experiment using ribose-OG-cobalamin. L. sativum was 
therefore grown with ribose-OG-cobalamin and, after sectioning, was imaged by confocal 
microscopy. This approach confirmed that L. sativum absorbs ribose-OG-cobalamin, which 
was found to localise to the vacuoles of the cotyledons (Figure 7). These results provide 
definitive evidence that some plants can absorb and transport cobalamin, at least by passive 
diffusion. The linear shape of the concentration response and high amounts of Cbl used in the 
experiment (see supplementary Figure S6) indicate an unspecific uptake mechanism. 
DISCUSSION. 
In this research we have demonstrated that it is possible to functionalise the main corrin 
framework by substituting the methyl group of SAM with either an allyl or propargyl group. 
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Although this approach was used to modify the C5 position, in theory it may be possible to 
modify any of the positions on the corrin ring that are methylated by SAM-dependent methyl 
transferases. Through this development we have shown that it is possible to generate either 
C5-allyl or C5-propargyl derivatives of HBA, and outlined how these can be transformed into 
cobyric acid analogues. By attaching fluorophores to the activated C5 allyl group it was 
possible to make C5-BoD and C5-OG cobyric acid derivatives. This has been achieved 
through the application of enzymatic and chemical tools to functionalize the comparatively 
inert corrin framework of B12. In doing so, we have been able to make analogues that can be 
used to investigate specific biological processes, expanding upon our initial research that 
allowed us to make different metal isosteres of cobalamin (Widner, et al., 2016). Our chemical 
and biological synthesis approach allows for a regio-specific modification to the corrin 
molecule. Other have developed methods to generate a reactive group on the corrin molecule 
through non-specific acid hydrolysis of cobalamin in order to isolate variants with a free acid 
side chain, which was then subsequently modified (Waibel, et al., 2008). This involves 
elaborate purification procedures and overall low yields. 
The success of our approach relies on combining biosynthetic enzymes with chemical 
synthesis to produce new functional analogues. We wondered whether the additional chemical 
space occupied around the C5 position would present a steric hindrance especially with the 
downstream biosynthetic enzymes. Indeed, the presence of the C5-allyl group on precorrin-8 
did reduce the rate of reaction with CobH, which catalyses the methyl migration from C11 to 
C12 in the formation of HBA. However, with knowledge of the 3-dimensional structure of the 
enzyme (Shipman, et al., 2001) we were able to rationally engineer more space into the active 
site of CobH to make it significantly more active with the C5-analogues.  
The amide groups in cobalamin are added by CobB and CobQ. CobB accepts the C5-allyl 
modified substrate well and transforms it into C5-HBA a,c-diamide in high yields. Normally, 
the next steps in the aerobic cobalamin pathway involve metal chelation and adenosylation. 
The amidation of the remaining side chains is only completed after the chelation and 
adenosylation processes have taken place. We wanted to change sequence of pathway 
reactions by completing the amidations prior to metal chelation, ie to transform HBAD into 
Hby. We were aware that some organisms must be able to make Hby as an intermediate, as 
reports from 40 years ago had highlighted that bacteria such as A. vinosum, when grown in 
the absence of cobalt, are able to produce cobalt-free corrinoids such as hydrogenobalamin 
(Koppenhagen, et al., 1973). We thus cloned cobQ from A. vinosum and demonstrated that 
the encoded enzyme is indeed able to convert HBA-diamide into Hby and similarly convert the 
C5 analogues into the C5-Hby equivalents. With all these enzyme tools in hand we were able 
to produce the C5-allyl Hby on the tens of mg scale. After coupling of the fluorophore to the 
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C5-allyl position cobalt was then inserted to generate the C5-cobyric acid analogues 
containing either an OG or BoD fluorophore. These cobyric acid analogues were then 
compared to cobalamin analogues where the fluorophores were attached to the ribose 
position. 
The functional analysis of the various corrin and cobalamin analogues was surprising. Addition 
of the C5-TPEA-cobyric acid to a microbial B12 bioassay plate promoted growth around the 
application point, indicating that the C5-material must be taken up by the S. enterica reporter 
strain, which then presumably converted it into a functional cobalamin analogue. The other 
analogues such as the C5-OG and C5-BoD variants also promoted growth, albeit less well. 
The high levels of the analogues required to promote growth reflect several constraints on 
their molecular recognition in terms of their uptake and incorporation into methionine synthase. 
For instance, it is clear from our results that the ribose-OG-cobalamin is taken up more 
efficiently than the C5-linked cobyric acid analogue, whilst, conversely, the C5-BoD-cobyric 
acid analogue is taken up more easily that the ribose-linked cobalamin equivalent. What is 
most surprising of all is that all these analogues appear to fit into the active site of methionine 
synthase. The crystal structure of the E. coli methionine synthase suggests that there is a 
certain amount of room to accommodate some extra bulk on the ribose group (Drennan, et 
al., 1994). However, within the corrin binding site there is less room for the further chemical 
space required for the C5-attachment. Nonetheless, as mentioned above, the same is true 
with CobH, the enzyme required to convert the modified C5-allyl-precorrin-8 intermediate into 
C5-allyl-HBA, where the enzyme still catalyses the reaction albeit at a reduced rate in 
comparison to the natural substrate. So, with methionine synthase the extra group on the 
corrin ring may force some conformational change within the protein so that the extra bulk is 
accommodated. There is always the possibility that the fluorescent analogues are broken 
down in the cell to release the fluorophore from the corrin. However, extraction of C5-BoD-
cobyric acid from E. coli that had been grown with the compound resulted only in the 
identification of intact C5-BoD-cobyric acid. Overall, this tells us that the S. enterica and E. coli 
uptake mechanisms will accept corrin and B12 analogues with significant extra chemical bulk 
and that these compounds are relatively active inside the cell. 
We investigated whether these fluorescent corrin analogues were also taken up by M. 
tuberculosis. Interestingly, both the C5-BoD-cobyric acid and the ribose-BoD-cobalamin 
analogues were taken up by cultured M. tuberculosis cells with the C5-BoD analogue 
appearing to be taken up more quickly than the ribose analogue. Significantly, both analogues 
appear to support growth of this B12-dependent TB strain indicating that the molecules are 
able to get inside the cells. The B12 uptake mechanism in M. tuberculosis, which is different to 
that found in most other bacteria (Gopinath, et al., 2013), is clearly able to take up incomplete 
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corrinoids.  As humans are not able to take up cobyric acid, the use of cobyric acid conjugates 
could prove a useful method for specifically labelling and targeting TB infections. 
There is still much to learn about how B12 makes its journey from bacteria to specific 
compartments in eukaryotic cells. Several recent reports have highlighted the fact that C. 
elegans may prove to be a good model to learn more about the movement, distribution and 
storage of B12 (Bito, et al., 2013; Bito, et al., 2017; Watson, et al., 2014; Yilmaz and Walhout, 
2014). Indeed, we were able to show that a fluorescent B12 derivative is absorbed from bacteria 
by C. elegans and is observed to accumulate within coelomocytes. Interestingly, only the 
ribose-linked cobalamin analogue was absorbed indicating that the worm is able to 
differentiate between complete and incomplete corrinoids. It is not clear whether this is due to 
the B12 analogue being recognised as foreign material or whether the cells represent a storage 
area for excess cobalamin. Nonetheless, the results demonstrate that this is a powerful model 
to learn about how B12 is absorbed and, as this system is different to mammalian systems, 
there is the possibility of exploiting this difference to try and treat worm-based parasite such 
as hook worms. 
It is well documented that vegetarians are more prone to B12 deficiency as plants lack B12 
(Stabler and Allen, 2004). However, it has been suggested that some plants are able to absorb 
the nutrient if added exogenously to their growth media (Mozafar, 1994; Sato, et al., 2004). 
Through an outreach project we demonstrated that that garden cress, L. sativum, can indeed 
take up cobalamin. The amount of B12 absorbed by garden cress is dependent upon the 
amount present in the growth medium, and displayed a linear rather than a hyperbolic 
relationship. This would suggest an unspecific form of uptake.  Nonetheless, we were able to 
confirm B12 uptake using our OG analogue of cobalamin, showing that the nutrient ends up in 
the vacuole in the leaf. The uptake of B12 into plants is irrelevant in terms of plant metabolism, 
since plants do not possess any B12-dependent enzymes, but the finding that some plants are 
able to accumulate B12 is important as such nutrient-enriched plants would be important in 




Vitamin B12, cobalamin, is an essential dietary component that is synthesised solely by certain 
prokaryotes. Although some eukaryotes, including mammals, require the nutrient, kingdoms 
such as Plantae and Fungi have evolved to live in a B12-less environment, which has 
implications for people on a vegan diet. In order to follow more closely the journey undertaken 
by cobalamin, from its prokaryotic inception, through sharing in microbial communities and its 
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uptake by animals, we devised ways to construct a range of fluorescent analogues of 
cobalamin. By manipulation of the B12 biosynthetic pathway we were able to modify the C5 
position of the corrin framework so as to incorporate an allyl substituent, where the vinyl group 
could be used to attach fluorophores to give tagged cobyric acid analogues. Fluorescent 
cobalamin variants were also constructed through attachment of fluorophores to the ribose 
group in the lower nucleotide loop. Together, these fluorescent analogues were used to show 
that M. tuberculosis is able to absorb both complete and incomplete corrinoids, demonstrating 
that cobalamin can be used to carry cargo into the cell. C. elegans was also found to absorb 
cobalamin, demonstrating that this approach can be used to follow intracellular trafficking in a 
model organism. Moreover, it also represents a target for parasites such as hook worms. 
Finally, and very surprisingly, certain plants were observed to be able to absorb B12 from their 
growth medium, accumulating the molecule in the leaf vacuole. This latter finding may be 
important as a way to address the global challenge of providing a nutrient-complete vegetarian 
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Figure 1. Biosynthesis of adenosylcobalamin from uroporphyrinogen III. Initially, 
uroporphyrinogen III is acted upon by the enzymes in the sequence of CobA, I, G, J, M, F, K, 
L and H to generate a cobalt-free corrinoid called HBA. Amidation of the a and c side chains 
followed by metal insertion, adenosylation and the remaining amidations by CobB, NST, R, O 
and Q gives rise to adenosylcobyric acid. The final stages of the biosynthesis see the 
attachment of an aminopropanol side chain and the alpha ribazole nucleotide, which contains 
the unusual base dimethylbenzimidazole. These reactions are mediated by the enzymes 
CobD, P, V and U. The numbering of the corrin macrocyle (1-20) is shown as is the lettering 
associated with the side chains (a-g). Different variants of cobalamin are found through 
changes in the highlighted areas of the molecule. The upper ligand (orange) can be a methyl, 
cyano or water group, the linking aminopropanol (purple) is an ethanolamine molecule in nor-
cobalamin, and a range of different bases can replace the dimethylbenzimidazole (blue). 
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Figure 2. The ChemBio synthesis of a C5 analogue of cobyric acid. Precorrin-7 is modified 
with an allyl-SAM derivative by the action of the C5 methyltransferase, CobL. This results in 
the production of C5-allyl-precorrin-8, which is acted upon by the enzyme CobH, B and Q to 
generate C5-allyl-Hby. Cysteamine is next chemically attached to the allyl group to generate 
C5-TPEA-Hby prior to the chemical insertion of cobalt to give C5-TPEA-cobyric acid. The 
coupling of a fluorophore via the free amine group on C5 generates the C5-fluorophore 
conjugate of cobyric acid. The fluorophore is represented by the filled red circle. 
Figure 3. Product complex of CobHT85A with C5-allyl-HBA. The figure shows the position 
of the reaction product bound at the active site of the enzyme. The proximity of the C5-group 
to Ala85 demonstrates how the removal of the threonine side chain has provided extra space 
to accommodate the allyl group. 
Figure 4. Chemical structures of the four fluorescent analogues of cobalamin.  The top 
two structures show the attachment of Orgeon Green and BoDIPY to the C5 position of the 
corrin ring, whereas the lower two structures show how these fluorophores are attached to the 
ribose moiety of the lower nucleotide loop. 
Figure 5. Effect of cobyric acid and cobalamin analogues on bacteria. Panel A shows a 
bioassay plate containing a S. enterica strain that requires cobyric acid or later pathway 
intermediates for growth. Addition of a known amount of vitamin B12 (spot 3) allows growth. 
Spots 1, 2 and 4 represent C5-Allyl-hydrogenobyrinic acid a,c-diamide (C5-Allyl-HBAD), C5-
Allyl-Hby and C5-TPEA-Hby, none of which promote growth. Spot 5 contains the C5-TPEA-
cobyric acid analogue and promotes growth. Panel B is the same bioassay plate assay as in 
panel A, with spot 3 containing a standard vitamin B12 solution. Spots 1, 2, 4 and 5 are 
solutions of C5-BoD-cobyric acid, ribose-BoD-cobalamin, C5-OG-cobyric acid and ribose-OG-
cobalamin, respectively. All the analogues support growth although the C5 analogues are 
weaker than the respective ribose-linked analogues. Panels C and D are overlay pictures of 
E. coli cells that have been grown in the presence of ribose-BoD-cobalamin and C5-BoD-
cobyric acid, respectively. The co-localisation of the red fluorescence with the cells indicates 
that E. coli has taken up both compounds. Panels E and F show cultures of M. tuberculosis, 
grown in the presence of ribose-BoD-cobalamin and C5-BoD-cobyric acid, respectively. 
Again, the presence of the red fluorescence with the cells indicates that M. tuberculosis is able 
to take up both analogues. 
Figure 6. Localisation of ribose-BoD-cobalamin to coelomocytes in C. elegans. C. 
elegans were fed with E. coli OP50 that had been grown in the presence of ribose-BoD-
cobalamin and were imaged after several days. The red fluorescence associated with the 
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fluorophore was found localised in the 6 coelomocytes, two of which are found at the head 
(Panel A), two near the vulva (Panel B) and two at the anus (Panel C). 
Figure 7. Localisation of ribose-OG-cobalamin to vacuoles in L. sativum (garden cress). 
Seeds were germinated in sterile media containing ribose-OG-cobalamin and were imaged 
after 5 days.  Thin sections of the cotyledons of cress grown in the presence of the ribose-
OG-cobalamin had highly fluorescent vacuoles (Panel A), whereas control plants grown in the 





CONTACT FOR REAGENT AND RESOURCES SHARING 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Professor Martin J. Warren (m.j.warren@kent.ac.uk) 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
All bacterial strains used in this study are listed in the Key Resources Table together with their 
source and genotypes. For E. coli, unless stated otherwise, the strains were grown in LB 
media supplemented with the appropriate antibiotics. All Mycobacterium tuberculosis cultures 
were grown in cobalamin deILFLHQW 6DXWRQ¶V GHILQHG PHGLXP 0.5 g KH2PO4, 0.5 g  
MgSO4·7H2O, 2 g citric acid, 0/05 g ferric ammonium citrate, 60 mLs glycerol, 4 g asparagine 
and 500 µL TWEEN 80 in 1 L pH 7.0. Worm studies were carried out with Caenorhabditis 
elegans var. Bristol (strain N2) and maintained on nematode growth medium (NGM) agar.  
 
METHODS DETAILS 
Chemicals and reagents. Oregon Green® 514 (OG) and BODIPY® TR-X (BoD) succinimidyl 
ester were both purchased from Thermo Fisher Scientific, Inc., as was the P-Per for plant 
extraction. Allyl-Bromide, Cysteamine hydrochloride, Seleno-L-methionine, Dowex 50WX4 
hydrogen form, Diethylaminoethyl±Sephacel, and N, N-DiisopropylethylamineReagentPlus® 
were bought from Sigma Aldrich, Ltd. Other chemicals and equipment include LICHROPREP 
RP-18 from VWR, VA-044 2,2'-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride from 
alpha laboratories Ltd. and crystal screens from Molecular Dimensions Ltd. 
 
Protein production and purification. All cobalamin biosynthetic genes were amplified by 
PCR using genomic DNA from either Rhodobacter capsulatus SB1003 (cobL, H and B), or 
Allochromatium vinosum ATCC 17899 (cobQ). The cob genes were amplified individually with 
primers then cloned into modified pET14b plasmids. These were then transformed into BL21 
star (DE3) pLysS. hMATIIA I117A was transformed into Rosetta 2 (DE3) pLysS. The 
recombinant strains were grown in LB at 37°C and protein overexpression was induced wit h 
0.4 mM of isopropyl-1-thio-ȕ-D-galactopyranoside. The cells were resuspended in buffer A (20 
mM Tris pH 8, 500 mM NaCl, 10 mM Imidazole) and sonicated. The protein was purified using 
Chelating SepharoseTM charged with NiSO4. Unbound proteins were washed off with buffer A, 
buffer A containing 30 mM imidazole and buffer A containing 80 mM Imidazole. Proteins were 
eluted with buffer A containing 400 mM imidazole and passed through a PD10 column 
equilibrated with buffer B (20 mM Tris, pH 8.0, containing 100 mM NaCl) for CobL and H, or 




Production and purification of precorrin-7. E. coli BL21 star (DE3) pLysS was transformed 
with pET3a/cobA-I-G-J-M-F-K-LC-E and grown in 2TY at 28 °C for 24 hours (Deery, et al., 
2012). The cells were resuspended in 20 mM Tris, pH 8.0, and sonicated. Proteins were 
precipitated with acetonitrile and following clarification by centrifugation precorrin-7 was 
purified over DEAE-Sepherose. The column was washed with 20 mM Tris, pH 8.0, containing 
100 mM NaCl, before elution with 500 mM NaCl. The pH of the eluent was lowered to pH 4.0 
with TFA and the precorrin-7 was further purified over RP18. The column was washed with a 
stepwise gradient of methanol in 0.1% (v/v) TFA and elution was achieved with 50% methanol. 
 
Synthesis of SAM analogues. Allyl-SAM was prepared from homocysteine and allylbromide 
as described previously (Wang, et al., 2011). AOO\OEURPLGHȝ/PPRODQG$J&O24 
(6 mg, 0.025 mmol) were added to S-adenosyl-L-homocysteine (5 mg, 0.013 mmol) dissolved 
in a mixture of formic acid and acetic acid (1:1, 0.6 mL) at 0 °C. The mixture was allo wed to 
warm up to room temperature and stirred continuously for 2.5 h. A further portion of allyl 
EURPLGHȝ/PPRODQG$J&O24 (6 mg, 0.025 mmol) were added and the reaction 
mixture was stirred for another 2.5 h. following centrifugation to remove the precipitate, H2O 
(3 mL) was added and the residual allyl bromide was extracted with diethyl ether (5 mL × 3). 
The aqueous phase was then concentrated under vacuum. 
 
Synthesis of Se-propargyl-L-selenohomocysteine. Se-propargyl-L-selenohomocysteine 
was synthesized from L-selenomethionine as described previously (Singh, et al., 2014). L-
selenomethionine (100 mg) was dissolved in 20 mL liquid ammonia at -78 ºC and stirred. 
Small fragments of sodium metal (34 mg) were added until a deep blue colour persisted for at 
least 1 min. Progargyl bromide (ȝ/) was then added followed by ammonium chloride (20 
mg). The reaction removed from the cooling bath and the flask was left open to the atmosphere 
for the ammonia to evaporate. The resulting residue was dissolved in H2O (5 mL) and the pH 
was adjusted to pH 5 - 7 by the addition of HCl (1 M). The solvent was removed under reduced 
pressure. 
 
Synthesis C5-allyl-HBA. Precorrin-7 (60 µM) was incubated with CobL (6 µM), CobH (30 
µM) and allyl-SAM (170 µM) in buffer B at 28°C for 16 hours in the da rk. The reaction mixture 
was then heated to 65°C and the precipitate was removed by centrifugation. The  resulting 
supernatant was applied to a DEAE-Sepharose column equilibrated in 20 mM Tris, pH 8.0. 
The column was washed with 20 mM Tris, pH 8.0, and the product was eluted with 20 mM 




Synthesis of C5-propargyl-HBA. C5-propargyl-HBA was prepared from precorrin-7 and Se-
propargyl-L-selenohomocysteine. Precorrin-  ȝ0 Se-propargyl-L-selenohomocysteine 
(1.5 mM), ATP (2 mM), MgCl2 P0K0$7$,$ȝ0&RE/ȝ0&RE+ȝ0
Se-propargyl-+F\  P0 DQG 6$++  ȝ0 ZHUH LQFXEDWHG LQ  P0 7ULV, pH 8.0, 
containing 100 mM NaCl at 28°C in the dark for 16 h. The reaction m ixture was heated to 
80°C for 15 minutes and the precipitate was removed by centrifugation. The supernat ant was 
applied to DEAE column pre-equilibrated in 20 mM Tris, pH 8.0. The column was washed with 
20 mM Tris, pH 8.0, containing 100 mM NaCl, and eluted with 20 mM Tris, pH 8.0, containing 
500 mM NaCl. 
 
Synthesis of C5-allyl-Hby. C5-allyl-HBA (30 µM), CobB (2 µM), CobQ (5 µM), ATP (8 mM), 
L-Glutamine (8 mM), and MgCl2 (20 mM) were incubated in buffer C at 28°C for 16 hours in 
the dark. The reaction mixture was heated to 80°C, acidified to pH 4 wit h trifluoroacetic acid 
(TFA) and the precipitate removed by centrifugation. The supernatant was applied to an RP18 
column equilibrated in 0.1% TFA, washed with 0.1% TFA followed by 20% methanol before 
elution in 50% methanol. The product was then dried in a vacuum centrifuge. 
  
C5 allyl group extension. The C5-allyl group was modified through a thiol-ene coupling 
reaction with cysteamine. A solution of C5-allyl-+E\ȝ0ZDVLQFXEDWHGDW&LQDFHWDWH
buffer (pH 4.0, 0.25 M) containing cysteamine (100 mM) and VA-044 (20 mM) in the dark for 
15 mins. The product was purified over RP18 and analyzed by HPLC-MS. 
 
Cobalt insertion. Cobalt insertion was achieved through incubation of the desired metal-free 
FRUULQRLGȝ0ZLWK&R&O2 (10 mM) in ammonium hydroxide (0.2 M) at 80 °C under an N 2 
atmosphere. The reaction was followed UV-visible spectroscopy until deemed complete (~ 60 
mins) after which it was quenched with KCN and the product purified over RP18 and eluted in 
methanol. 
 
Synthesis of fluorescent C5-cobyric acid derivatives. CN2-C5-TPEA-cobyric acid was 
dissolved in DMSO and either the succinimidyl ester of OG or BoD along with 2 equivalents 
of DIPEA were added. The reaction was stirred at room temperature for 16 hours in the dark. 
The solvent was removed in vacuo and the compound was purified by semi-preparative HPLC. 
 
Ribose linked fluorescent vitamin B12 derivatives. The ribose-¶-hydroxyl group of vitamin 
B12 was activated with carbonyldiimidazole and coupled with 1,2-diaminoethane as described 
previously (McEwan, et al., 1999). The derivative was added to either the succinimidyl ester 
of OG or BoD with 2 equivalents of DIPEA in DMSO. The reaction was stirred for 16 hours in 
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the dark at room temperature. The product was precipitated with acetone and collected by 
filtration. Fluorescent derivatives were dissolved in 50% acetonitrile and purified by semi-
preparative HPLC. 
 
Crystal structure determination of CobHT85A with bound C5-allyl-HBA. Recombinantly 
produced CobHT85A was purified on a nickel affinity column. After affinity purification CobHT85A 
was subject to gel filtration on a G200 Superdex column (GE Healthcare). Protein fractions 
were collected and concentrated to 7 mg mLí1. Allyl-HBA was added to the protein in a 1:1 
ratio prior to crystallisation at 19°C using the hanging drop vapour diffusion method. Initial 
crystals were obtained in 0.2 M calcium acetate hydrate, 0.1 M sodium cacodylate pH 6.5, 18 
% (w/v) PEG 8000 (Molecular Dimensions, MD01 condition 20). Crystal optimisation required 
the addition of 20% methanol to the well condition and increasing the PEG 8000 to 20%. This 
resulted in multiple square shaped crystals which formed within three days. A single crystal 
was picked, transferred to a drop of in 0.2 M calcium acetate hydrate, 0.1 M sodium cacodylate 
pH 6.5, 20 % (w/v) PEG 8000 containing 20% glycerol as a cryoprotectant and then flash 
frozen in liquid nitrogen. The crystal diffracted to 1.6 Å and was found to belong to space group 
C 1 2 1 which is the same as the published structure of R. capsulatus CobH co-crystallised 
with HBA (PDB 4AU1) (Deery, et al., 2012). Data for the crystal was collected using beamline 
IO4-1 at the Diamond Light Source (UK). The data was auto-integrated and scaled using the 
Xia2 package using XDS (X-ray data software) and XSCALE (3dii) at the beamline. An initial 
model was generated by refinement of the scaled and merged data against PDB:4AU1 in 
Refmac 5. The model was then refined through cycles of manual model building in Coot and 
refinement with Refmac 5. The final model was validated in Coot and with wwPDB. The PDB 
coordinates were deposited with the code 5N0G. 
 
Bioassay plates. A quantitative bioassay using S. typhimurium AR3612 was performed as 
described previously (Raux, et al., 1996). The bioassay plates containing the indicator strain 
AR3612 were prepared from lawns of the corresponding bacteria. The bacteria were scraped 
from an overnight minimal medium (M9) plate containing methionine (50 mg/L) and cysteine 
(50 mg/L) and washed with 0.9 % (w/v) NaCl to remove traces of methionine. The cells were 
mixed with 300 mL of minimal medium (M9) containing cysteine (50 mg/L) agar at 47 °C, and 
poured into plates. 
 
Imaging in Escherichia coli. The OP50 E. coli was transformed with pET-BAD-btuBF and 
grown in a 4 mL LB culture after inoculation with 16 µL of starter culture. This was grown with 
1 µM of C5-BoD-cobyric acid or ribose-BoD-cobalamin overnight with induction with 0.02% 
arabinose. Cultures (1 mL) were spun down and washed three times with fresh LB to remove 
28 
 
external fluorophore. The final pellet was resuspended in 1 mL of fresh LB, 5 µL of this culture 
was dried on to a 1 % (w/v) LB-agarose pad and imaged on an Olympus IX81 widefield 
microscope with PlanApo 150 x OTIRFM-SP 1.49 numerical aperture lens mounted on ASI 
stage (Applied Scientific), and illuminated using LED light sources (Cairn Research Ltd) with 
appropriate filters (YFP and mCherry, Chroma). The samples were visualised using a 
Princeton ProEM 1024 back-thinned EMCCD camera (Princeton Instruments) on Metamorph 
software (Molecular Devices). Each 3D-maximum projection of volume data was calculated 
from 13 z-SODQHLPDJHVHDFKȝPDSDUW 
Imaging in Mycobacterium tuberculosis. Relevant strains of M. tuberculosis were grown in 
150 µL cultures in a 96 well plate containing various concentrations of the BODIPY-labelled 
analogues of cobalamin and cobyric acid. The cells were grown for up to 48 h. After growth, 
the cells were spun down and washed three times to remove the fluorophore. Cells were 
pipetted directly onto a slide and imaged live on a Leica SP5 microscope using 594 nm 
excitation and imaging between 600-700 nm. The images were processed using Leica Lite 
confocal software and FIJI (Schindelin, et al., 2012).  
Extraction of cobalamin from Lepidium sativum using P-Per. Lepidium sativum seeds 
were sterilised by washing with 70 % ethanol three times then rinsed five times with sterile 
water. The seeds were placed on Murashige-Skoog agar containing different concentrations 
of cobalamin, and grown for one week in sunlight at room temperature. The cotyledons of the 
cress were collected and washed 5 times with water.  The residual water was removed by 
pipette, after centrifugation. The P-Per was prepared as instructed in the enclosed manual 
(Thermo Fisher): 283 µL reagent A, 2.9 µL of reagent B, and 214 µL of reagent C. A little sand 
was added to the cotyledons along with 100 µL of the P-Per. The cotyledons were ground 
using a hand-held pellet pestle for 2 minutes. The suspension was vortexed and then 
centrifuged for 3 minutes at 15,000 rpm rotation. The lower aqueous phase was collected and 
applied to the bioassay plate (see Section 2.6.1). 
Imaging in L. sativum. L. sativum seeds were sterilised by washing with 70 % ethanol three 
times, then rinsed five times with sterile water. The seeds were placed on the Murashige-
Skoog agar with 0.5 µM ribose-OG cobalamin, and grown at room temperature in the dark for 
five days. Whole cotyledons or sectioned cress were placed directly on the glass slide with 
water. The samples were imaged with a Leica TCS SP2 laser scanning confocal microscope 
(Leica Microsystems, Germany) with AOBS (Acoust-Optical Beam Splitter) detected using 
PMTs (photomultiplier tubes). Both the 40 x and 63 x HCX PL APO oil lenses, numerical 
aperture 1.25 and 1.4 respectively, were used. Samples were excited at 514 nm from an 
Argon±Krypton-mixed gas laser and images were acquired in the green/yellow region of the 
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light spectrum (525±590 nm). The software used to image was LCS (Leica Confocal Software) 
and the images were processed using Leica Lite confocal software and FIJI (Schindelin, et 
al., 2012). 
Imaging in Caenorhabditis elegans. C. elegans were maintained on normal E. coli OP50 at 
Û&XQOHVVRWKHUZLVHVWDWHG$IRRGVRXUFHFDUU\LQJWKHIOXRUHVFHQWDQDORJXHVZDVPDGH
by transforming the OP50 with pET-BAD-btuBF and were grown in a 4 mL LB culture after 
inoculation with 16 µL of starter culture. This was incubated with 1 µM of C5-BoD-cobyric acid 
or ribose-BoD-cobalamin overnight with induction with 0.02% arabinose. 1 mL of culture was 
spun down and washed three times with fresh LB to remove external fluorophore. The final 
pellet was resuspended in 1 mL of fresh LB and 200 µL of the OP50 culture was pipetted on 
to the centre of NGM agar plates. These plates were left to dry in a sterile culture hood for 4 
hours and then stored at 4 °C until used. Three forth larval stage (L4) C. el egans were 
transferred to the seeded plates and left to grow at 20 °C for four days bef ore imaging. Three 
third larval stage (L3) C. elegans were transferred to the seeded plates and allowed to lay 
eggs. These progeny were then imaged at the L4 stage. 
For each slide, 3-5 L4 stage C. elegans were mounted in M9 + 0.2 % levamisole on a 2 % 
agarose pad and imaged within 30 min at the University of Bristol on a Leica SP8X AOBS 
confocal laser scanning microscope attached to a Leica DMi8 inverted epifluorescence 
microscope with µ$GDSWLYH)RFXV&RQWURO¶7KHVDPSOHZDVH[FLWHGZLWKDZKLWHOLJKWODVHUDW
594 nm and detected between 599-712 nm using a hybrid gated detector for the fluorophore, 
and excited with a 405 nm laser, with images acquired between 410-505 nm for the gut granule 
autofluorescence. All images were taken using a 20 x numerical aperture 0.75 dry lens. Again 
the images were processed using Leica Lite confocal software and FIJI (Schindelin, et al., 
2012). 
HPLC MS analysis. Samples were separated on an Agilent 1000 series HPLC coupled to a 
micrOTOF-Q II (Bruker) mass spectrometer using an Ace 5 AQ column (2.1 x 150 mm; 
$GYDQFHG &KURPDWRJUDSK\ 7HFKQRORJLHV PDLQWDLQHG DW ÛC and with a flow rate of 0.2 
mL/min. The mobile phase consisted of 0.1% TFA (v/v) in water (solvent A) and 100% 
acetonitrile (solvent B). Three different HPLC gradients were employed. Gradient 1 
(methionine and SAM and analogues):  Linear gradient from 0-30% solvent B over 30 mins. 
Gradient 2 (pathway intermediates): 5-20% B over 6 mins, 20-30% B over 19 mins followed 
by 30-90% B over 5 mins. Gradient 3 (fluorescent cobalamin analogues): Linear gradient from 
0-100% solvent B over 45 mins. Semi-preparative HPLC was performed on an Agilent 1000 
VHULHV+3/&XVLQJD&66,/&FROXPQPP[PPȝP&KDUOWRQ6Fientific) at a 




NMR analysis. NMR experiments were performed using a 600 MHz (1H) Bruker Avance III 
spectrometer with a 5 mm QCI-F cryoprobe. Assignments were completed using DQF-COSY, 
TOCSY (20 ms and 80 ms mixing times), NOESY (500 ms mixing time), 13C-HSQC-TOCSY, 
13C,1H-HSQC and 13C,1H-HMBC experiments with WaterGATE or excitation sculpting water 
suppression on 0.1-1 mM samples dissolved in deuterium oxide.  All 13C data was obtained 
using natural isotopic abundance. Data were processed and analysed using Bruker Topspin 
version 3.2 and CCPN analysis. 1H Chemical shift referencing was based on the position of 
the water resonance, 13C referencing used 1H/13C gyromagnetic ratios to define indirect carrier 
position (Wishart and Case, 2001) and all data were obtained at 25°C.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS  
Bioassays (Figure 5 and Supplementary Figure 6) were performed three times (n=3) and the 
values for the amount of B12 present in the samples was generated from a standard curve. For 
B12 uptake into plants the averages of the separate measurements were then calculated and 
plotted using Microsoft Excel. The structure of CobH was refined with internal statistical 
analysis as reported in the deposition in the PDB 
No additional statistical tests were performed.  
 
DATA AND SOFTWARE AVAILABILITY 
All software used in this study is reported in Method Details and indicated in the Key 
Resources Table. The coordinates for the CobH T85A crystal structure were deposited in the 
Protein Data Bank PDB:5N0G (https://www.rcsb.org/structure/5n0g). 
 
 
